Figures
Lab/R&D Fundamentals Weaken Despite Improving Demand Drivers
U.S. Life Sciences | Q2 2026
July 31, 2026 2 Minute Read
Looking for a PDF of this content?
Executive Summary
- Lab/R&D net absorption was negative for the second consecutive quarter at -1.2 million sq. ft., driven by occupancy declines in West Coast markets.
- The lab/R&D vacancy rate reached a new high of 23.8%.
- Average triple-net asking rent fell by 8.1% year-over-year to $65.95 per sq. ft., the sixth consecutive quarterly drop.
- Biotech R&D employment growth rose at its fastest pace since mid-2023, while annual venture capital funding reached its highest level since Q3 2022
- Tenant requirements for lab/R&D space increased for the first time in a year by nearly 500,000 sq. ft.